Society of Industry Leaders: Help for Investors

The shifting pharma landscape makes it all the more important that investors make intelligent choices where to invest their money. The Society of Industry Leaders provides institutional money managers with timely information about the current state of the pharmaceutical market and how it is likely to progress.

Managing Cross Boundary Issues

Pharmaceutical companies are notorious for their functional and organizational silo structure built around brands. Strategic issues that cross silos -- i.e., cross-boundary issues such as getting marketing and R&D working together, getting a more coordinated global approach to marketing, or getting companies to work better in marketing alliances-are thornier than most because managers don't control all the necessary resources and communication and trust are often weak.

eDetailing: Yesterday, Today and Tomorrow

eDetailing proponents, inside pharma companies and outside, use survey data to justify their arguments for greater spending on eDetails. In some cases, however, the numbers seem to show confusing trends and even may suggest that eDetailing may not be all that it's cracked up to be.

Insomnia – the Next DTC Frontier

You've probably seen ads on TV and in print for several new drugs to treat insomnia. FDA-approved drugs for this condition include AMBIEN (Sanofi-Aventis),...

4th Annual Technology Supported Physician Detailing

Leverage Mobile Detailing to Deliver Targeted, Engaging and Valuable Product Information to Physicians

2nd Annual Direct to Consumer Strategies for Medical Devices

Join us at the leading event for medical device marketing to hear more high-level, informative presentations and gain insight into new regulatory compliance updates, key marketing techniques and ROI models for successful DTC campaigns.

CBI’s Annual Recall Summit

Hear from Rx, OTC, medical device companies and leading industry associations about how to examine and minimize potential liability issues, prepare for the logistical aspects of a recall and evaluate whether to outsource the recall process.

4th Annual Conference on Off-Label Usage

Distinguish lawful off-label communication from illegal off-label promotion

FDA May Follow PhRMA’s Lead on DTC

In November, the FDA will host a 2-day public meeting on direct-to-consumer (DTC) promotion of regulated products, including prescription drugs. According to the September...

Forum on Disease Awareness and Patient Education for the Pharmaceutical Industry

Featured Conference Forum on Disease Awareness and Patient Education for the Pharmaceutical Industry September 22 -...